Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sepsis 1Neoplasms 1

Interventions

telavancin 1soybean oil, phospholipid emulsion 1drotrecogin alfa activated 1Trimethoprim, Sulfamethoxazole Drug Combination 1Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1Simvastatin 1Saline Solution 1Povidone-Iodine 1Methods 1Meropenem 1Massage 1Levofloxacin 1Hydrochloric Acid 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gentamicins 1Colistin 1Colchicine 1ClinOleic 1Anti-Bacterial Agents 1Amoxicillin-Potassium Clavulanate Combination 1Alkaline Phosphatase 1Acupuncture Therapy 12-Propanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sepsis × Hydrochloric Acid × Clear all
NCT05376566 2026-03-24

Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections

Rigshospitalet, Denmark

Phase NA Completed
212 enrolled

Neoplasms, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡